unknown by Liang Zhong et al.
BioMed CentralBioMedical Engineering OnLine
ssOpen AcceResearch
Passive and active ventricular elastances of the left ventricle
Liang Zhong†1, Dhanjoo N Ghista*†1,2, Eddie YK Ng1 and Soo T Lim3
Address: 1College of Engineering, School of Mechanical and Production Engineering, Nanyang Technological University, 50 Nanyang Avenue, 
Singapore 639798, 2Bioengineering Division, College of Engineering, Nanyang Technological University, Singapore, 639798 and 3Department of 
Cardiology, National Heart Centre, SingHealth, Mistri Wing, 3rd Hospical Ave., Singapore, 168572
Email: Liang Zhong - pg01538918@ntu.edu.sg; Dhanjoo N Ghista* - mdnghista@ntu.edu.sg; Eddie YK Ng - mykng@ntu.edu.sg; 
Soo T Lim - LIM_SOO_TEIK@nhc.com.sg
* Corresponding author    †Equal contributors
Abstract
Background: Description of the heart as a pump has been dominated by models based on
elastance and compliance. Here, we are presenting a somewhat new concept of time-varying
passive and active elastance. The mathematical basis of time-varying elastance of the ventricle is
presented. We have defined elastance in terms of the relationship between ventricular pressure
and volume, as: dP = EdV + VdE, where E includes passive (Ep) and active (Ea) elastance. By
incorporating this concept in left ventricular (LV) models to simulate filling and systolic phases, we
have obtained the time-varying expression for Ea and the LV-volume dependent expression for Ep.
Methods and Results: Using the patient's catheterization-ventriculogram data, the values of
passive and active elastance are computed. Ea is expressed as:
; Epis represented as: . Ea is deemed to
represent a measure of LV contractility. Hence, Peak dP/dt and ejection fraction (EF) are computed
from the monitored data and used as the traditional measures of LV contractility. When our
computed peak active elastance (Ea,max) is compared against these traditional indices by linear
regression, a high degree of correlation is obtained. As regards Ep, it constitutes a volume-
dependent stiffness property of the LV, and is deemed to represent resistance-to-filling.
Conclusions: Passive and active ventricular elastance formulae can be evaluated from a single-beat
P-V data by means of a simple-to-apply LV model. The active elastance (Ea) can be used to
characterize the ventricle's contractile state, while passive elastance (Ep) can represent a measure
of resistance-to-filling.
Background
The heart may be conceived as a pump that receives blood
from a low-pressure system and raises it to a high-pressure
system. Although the mechanism responsible for genera-
tion of wall stress (and hence left ventricular (LV) pres-
sure) is contraction of the myocardial fibers, an analytical
formulation linking the myocardial and LV dynamics is
still lacking. In the absence of this formulation, a popular
way of linking LV pressure and volume dynamics is by
means of LV compliance (or elastance) [1,2]. Although
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BioMedical Engineering OnLine 2005, 4:10 http://www.biomedical-engineering-online.com/content/4/1/10this yields the cyclic values of elastance and compliance,
this concept does not provide an intrinsic measure of
elastance and compliance for the contractile state of the
LV.
The concept of compliance or elastance was first
employed for blood vessels [3], by relating incremental
cross-section area (or volume) and transmural pressure.
Warner appears to be have been the first to adopt a com-
pliance description for a dynamic heart [4]. In Warner's
description, a mean value of compliance is adopted for
diastolic phase and another mean value for systole, with
abrupt transitions between the two states.
Defares [5] avoided the stepwise transition between
diastolic and systolic compliance, by making elastance a
continuously varying function of time. Later, the concept
of a continuously varying compliance or elastance was
adopted by a number of investigators with diverse varia-
tions [2,6,7]. Nevertheless, they all share the concept of a
simple and extrinsic compliance term as an adequate
description of ventricular mechanics during the cardiac
cycle, based on monitored values of LV pressure and
volume.
Classically, ventricular compliance is defined, at any point
in time, as the change in ventricular volume concomitant
with the change in ventricular pressure, such that
C = dV / dP, E = dP / dV  (1)
If C is assumed constant, this equation becomes a linear
relation, whose integration gives
V = CP + Vc  (2)
where Vc is an integration constant. If the compliance var-
ies with time, then all terms in equation (2) may vary with
time, as:
V (t) - Vc (t) = C(t)P(t)  (3)
In this context, Suga [8] opted for the definition of ven-
tricular elastance as
to represent the elastance of the contracting LV, where Vd
represents the unstressed LV volume corresponding to
zero LV-pressure, obtained by drawing a tangent to P-V
curves at end-ejection, as illustrated in Figure 1. This
model gave rise to the development of the end-systolic
pressure-volume relation (ESPVR) as a measure of con-
tractility [9-14].
However, the determination of the maximal slope Emax
and of the volume-axis intercept (Vd) of the tangent to the
P-V curve at end-ejection (as a measure contractility of the
cardiac muscle) is not only unreliable [11,15], but also
requires generation of multiple P-V loops under variations
loading conditions [11,15]. It is hence impractical to use
clinically for a specific LV catheterization-ventriculogra-
phy data. Above all, all of these variations in the concept
of E obtained from LV pressure-volume data fail to
explain the phenomena of LV suction and LV pressure
drop during early filling as well as the generation of LV
pressure increase during isovolumic contraction.
We have hence come up with a new concept of dual pas-
sive and active elastances operating throughout the car-
diac cycle. The passive elastance (Ep) represents the LV
pressure response to LV volume change (to LV volume
increase during LV filling phase and to LV volume
decrease during LV ejection phase). However, simultane-
ously, we also have active elastance (Ea) representing the
contraction of the left ventricle due to its sarcomeric acti-
vation (and the development of force between the actin-
myosin units) and relaxation (due to disengagement of
the actin-myosin units).
LV Ea develops after the start of isovolumic contraction,










Schematic drawing of P-V loops and end-systolic P-V relation (ESPVR)Figure 1
Schematic drawing of P-V loops and end-systolic P-V 
relation (ESPVR). Schematic drawing of P-V loops and 
end-systolic P-V relationship (ESPVR) with a positive volume 
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BioMedical Engineering OnLine 2005, 4:10 http://www.biomedical-engineering-online.com/content/4/1/10thereafter decreases and becomes zero during diastolic
filling. On the other hand LV Ep starts increasing after the
initiation of LV filling as the LV volume increases. It
reaches its maximum value at the end-of-filling phase,
remains constant during isovolumic contraction, and
thereafter decreases during ejection (as the LV volume
decreases). While the generation of Ea helps us to explain
the development of the LV pressure increase during isovo-
lumic contraction, the decrease of Ea during diastole helps
us to explain the decrease in LV pressure during early fill-
ing. The incorporation of both Ep and Ea helps us to




The subjects in this study were studied in a resting recum-
bent (baseline) state, after premedication with 100–500
mg of sodium pentobarbital by retrograde aortic catheter-
ization. Left ventricular chamber pressure was measured
by a pigtail catheter and Statham P23Eb pressure trans-
ducer; the pressure was recorded during ventriculography.
Angiography was performed by injecting 30–36 ml of
75% sodium diatrizoate into the LV at 10 to 12 ml/s. It has
been found by using biplane angiocardiograms that calcu-
lated orthogonal chamber diameters are nearly identical
[16]. These findings are used to justify the use of single-
plane cine techniques, which allow for beat-to-beat anal-
ysis of the chamber dimensions.
For our study, monoplane cineangiocardiograms were
recorded in a RAO 30° projection from a 9 in image inten-
sifier using 35 mm film at 50 frames/s using INTEGRIS
Allura 9 system at the Nation Heart Centre (NHC), Singa-
pore. Automated LV analysis was carried out to calculate
LV volume and myocardial wall thickness. The LV data,
derived from the cineangiographic films and depicted in
Figure 2 consists of measured volume and myocardial
thickness of the chamber as well as the corresponding
pressure. All measurements are corrected for geometric
distortion due to the respective recordings systems.
In Figure 2, it is noted that during the early filling phase,
LV pressure decreases even though LV volume increases.
This phenomenon is defined as the 'LV suction effect',
which will be explained later by using our concepts of
active and passive elastances. This phenomenon is also
depicted in Figure 3 and Table 1.
A case study of measured LV pressure, volume and wall thi kne s during a cardiac cycleFigur  2
A case study of measured LV pressure, volume and 
wall thickness during a cardiac cycle. An example of a 
patient's measured LV pressure, volume and wall thickness 
during a cardiac cycle; t = 0-0.08s is the isovolumic contrac-
tion phase, t = 0.08s-0.32s is the ejection phase, t = 0.32s-
0.40s is the isovolumic relaxation phase, and t = 0.40s-0.72s 
is the filling phase. Note that even after 0.4 s, the LV pressure 
still continues to decrease from 17 mmHg (at 0.4s, at start of 
filling) to 8 mmHg at 0.44s.
Relationship between LV volume and pressure for the data of figure 2Figure 3
Relationship between LV volume and pressure for 
the data of figure 2. Relationship between LV volume and 
pressure for the data of Figure 1. Points (21–36) constitute 
the filling phase, (1–5) constitute the isovolumic contraction 
phase, (5–17) constitute the ejection phase, and (17–21) con-
stitute the isovolumic relaxation phase. Note that after point 
21, the LV pressure decreases; this characterizes LV suction 
effect.Page 3 of 13
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LV
At the start of diastolic-filling phase, the LV incremental
pressure dPLV is the response to (i) LV Ea continuing to
decrease due to the sarcomere continuing to relax well
into the filling phase, and (ii) to the rapid inflow of blood
and the corresponding increase in LV volume, along with
increase in LV Ep. The associated governing differential
equation, relating LV pressure and volume, can be put
down (by referring to the Appendix for its derivation) as
[17]:
where t represents the time variable (s) from the start of
filling phase;
V represents the volume of LV (ml) during the filling
phase;
PLV represents pressure of the LV, in mmHg (hereafter
symbolized by P) (mmHg);
M represents the inertia term = [LV wall-density (ρ)/(LV
surface-area/wall-thickness)] = ρh / 4πR2, for a spherical
LV model (in mmHg/(ml/s2));
Table 1: Computed values of Ea and Ep during the cardiac cycle, for subject HEL
Point Phase Time Pressure Volume Ea Ep
1 Isovolumic contraction 0 18 136.7 0 0.968314
2 0.02 22 135.7 0.051287 0.930811
3 0.04 32 134.6 0.153167 0.891234
4 0.06 52 133.5 0.282331 0.853339
5 0.08 80 132.5 0.424912 0.820289
6 Ejection 0.1 94 129 0.570602 0.714374
7 0.12 103 124.5 0.711775 0.598039
8 0.14 110 119.3 0.843116 0.486996
9 0.16 113 114 0.961299 0.395008
10 0.18 116 107.3 1.06464 0.303159
11 0.2 118 101.8 1.15275 0.243961
12 0.22 120 97.5 1.22616 0.205852
13 0.24 121 94 1.28607 0.179272
14 0.26 122 91 1.334 0.159239
15 0.28 120 88 1.37114 0.141444
16 0.3 116 85.5 1.34002 0.128144
17 0.32 100 84.3 1.15107 0.122212
18 Isovolumic relaxation 0.34 74 85 0.846411 0.125638
19 0.36 50 85.5 0.523931 0.128144
20 0.38 30 86.4 0.269515 0.132782
21 0.4 17 90.6 0.113989 0.156743
22 Filling 0.42 10 105 0.0392726 0.276831
23 0.44 8 112 0.0109316 0.365003
24 0.46 8.4 117 0.00244008 0.444703
25 0.48 9 119 0.00043378 0.481259
26 0.5 9.6 120.2 6.10272e-005 0.50462
27 0.52 10.2 121 6.75442e-006 0.520821
28 0.54 10.5 121.4 5.84848e-007 0.529115
29 0.56 10.7 121.6 3.94098e-008 0.533312
30 0.58 10.8 121.8 2.0564e-009 0.537542
31 0.6 11 122 8.2698e-011 0.541805
32 0.62 11.8 124 2.55156e-012 0.586344
33 0.64 12.8 127 6.01397e-014 0.66011
34 0.66 14.5 130.7 1.07837e-015 0.763991
35 0.68 17 134 1.46518e-017 0.87036
36 0.7 20 136.6 1.50271e-019 0.964497
37 0.72 18 136.7 1.15909e-021 0.968314
M dV d EV M dV VdE EdV dPLV( ) ( ) ( ) + = + + = ( )5Page 4 of 13
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Likewise during ejection, the LV pressure variation (dPLV)
is caused by both Ea variation as well as Ep decrease. The
instantaneous time-varying ventricular elastance (E) is the
sum of (i) volume-dependent passive elastance (Ep) and
(ii) active elastance (Ea) due to the activation of the LV sar-
comere. Hence,
E = Ea + Ep  (6)
We will now provide the expressions for Ep and Ea, and
then their formulations. The passive (unactivated)
myocardium exhibits properties of an elastic material,
developing an increasing stress as strain increases, as
occurs during ventricular filling. The passive stress-strain
relation of myocardial muscle strip is nonlinear, and
therefore cannot be described by Hooke's law. As an
approximation, it follows an exponential relationship
[18-20]. Therefore, the relation between LV passive pres-
sure and volume has also been assumed to be
exponential. Since Ep (= dP/dV) is volume-dependent, we
can express it as:
where Ep0 is the passive elastance coefficient, zp is the pas-
sive elastance exponent, and V is the LV volume; its deri-
vation is provided in a subsequent section.
On the other hand, we will represent Ea as an intrinsic
property of the LV (derived later), as:
where (i) t is measured from the start of isovolumic con-
traction, (ii) the parameter Ea0 is the active elastance
coefficient, (iii) the time-coefficient (τC) describes the rate
of elastance rise during the contraction phase, while (τR)
describes the rate of elastance fall during the relaxation
phase; (iv) the exponents "ZC" and "ZR" are introduced to
smoothen the curvatures of the Ea curve during
isovolumic contraction and relaxation phases; (v) the
parameter d is a time constant whose (to be determined)
value is during the ejection phase, and (vi) u(t-d) is the
unit step function, u(t-d) = 0 for t<d. The rationale for
equation (8), as provided in the next section, is based on
Ea incorporating parameters reflecting the (i) generation
of LV pressure during isovolumic contraction, (ii)
decrease of LV pressure during isovolumic relaxation and
early filling, and (iii) the LV pressure-volume relationship
during filling and ejection phase.
Our hypothesis
Based on equations (5–8), our hypothesis is that both Ea
and Ep contribute to the relationship of LV pressure and
volume. While Ep incorporates LV pressure change due to
LV volume change, Ea incorporates the effect of LV myo-
cardial activation in the generation of LV pressure during
the isovolumic phases (when the LV volume remains con-
stant). Since Ea is deemed to be the basis of LV pressure
generation, its variation (as given by equation 8) corre-
sponds to the LV pressure variation.
Determination of Ea and Ep expressions
a) Active elastance (during isovolumic contraction and relaxation)
During isovolumic contraction (because dV = 0, 
and Ep is constant), the governing equation (5) becomes
VdE = dPLV, which can be detailed as:
Vi(Ei - Ei-1) = Vi[(Ea,i + Ep,i) - (Ea,i-1 + Ep,i-1)] = Vi(Ea,i + Eped -
Ea,i-1 - Eped) = dPLV,i  (9)
where i is a time instant during the isovolumic contraction
and relaxation, Vi and PLV,i are the monitored LV volume
and pressure at this instant, and Eped is the passive
elastance at the end-diastolic phase.
Also, during isovolumic relaxation (because dV = 0,
 and Ep is constant), the governing equation (5)
becomes VdE = dPLV, which can be represented as:
Vi (Ea,i + Ep,i - Ea,i-1 - Ep,i-1) = Vi (Ea,i + Epes - Ea,i-1 - Epes) = dPLV,i
 (10)
where Epes is the passive elastance at the end-systolic phase
Now, applying equations (9 & 10) to the case shown in
the Figure 2, we have (using the monitored LV pressure-
volume data):
1. For isovolumic contraction
Ea,1 = 0  (11-a)
Ea,2 = (P2 - P1)/V2 + Ea,1 = 0.029477 mmHg/ml  (11-b)
Ea,3 = (P3 - P2)/V3 + Ea,2 = 0.103771 mmHg/ml  (11-c)
Ea,4 = (P4 - P3)/V4 + Ea,3 = 0.253584 mmHg/ml  (11-d)
Ea,5 = (P5 - P4)/V5 + Ea,4 = 0.463599 mmHg/ml  (11-e)
2. For isovolumic relaxation
Ea,18 = (P18 - P17)/V18 + Ea,17 = Ea,17 - 0.058954 mmHg/ml
 (11-f)
E dP dV E ep p
z Vp= = ( )( / ) 0 7
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 (11-g)
Ea,20 = (P20 - P19)/V20 + Ea,19 = Ea,17 - 0.312656 mmHg/ml
 (11-h)
Ea,21 = (P21 - P20)/V21 + Ea,20 = Ea,17 - 0.463599 mmHg/ml
 (11-i)
Now in the above expressions 11(f-i), Ea,17 at end-ejection
is unknown. For different representative values of Ea,17, we
can get different Ea curves. We need to determine the opti-
mal value of Ea,17, such that Ea can be described by a
smooth curve to fit both isovolumic contraction and ejec-
tion phases. In Figure 4, we have determined Ea,17 = 1.1
mmHg/ml, and the polynomial expression for Ea(t) to fit
its above calculated values during isovolumic contraction
and relaxation. However, in order to (i) more suitably rep-
resent Ea to correspond with its role during the cardiac
phases (isovolumic, ejection and filling), and (ii) because
of the sigmoidal shape of Ea curve and its variation resem-
bling the LV pressure variation during systole (as seen in
Figure 4), we express Ea (according to equation 8) as:
So that its constituent parameters have physiological sig-
nificance as indicated following equation (8).
Hence, to compute Ea(s) during isovolumic contraction,
when u(t-d) = 0, we employ the expression
and determine its parameters Ea0, τC and ZC to fit the mon-
itored pressure-volume data. Then, to compute Ea(s) dur-
ing isovolumic relaxation, we employ the total expression
and determine its remaining parameters d, τR and ZR to fit
the measured pressure-volume data.
For the sample data of Figure 2, the variation of Ea is
depicted in Figure 5, along with the values of its parame-
ters. We now propose that Ea can be employed as an index
of contractility.
b) Passive elastance determination during diastolic filling
During the diastolic filling phase, equation (5) becomes
Ea vs. time for the data of figure 2Figure 4
Ea vs. time for the data of figure 2. Points (1–5) are the 
computed values of Ea during isovolumic contraction phase, 
based on equations 11(a-e). In the isovolumic relaxation 
phase, the computed values are represented by the symbol 
∆, for Ea,17 = 1.1 mmHg/ml. The best fit for Ea during isovolu-
mic contraction and relaxation phase is given by the curve: Ea 
= -12000t6 + 17000t5 - 7700t4 + 1100t3 + 19t2 + 0.59t + 
0.00056
The data of figure 2 is fitted with equation (8)Figure 5
The data of figure 2 is fitted with equation (8). When 
the patient data of Figure 2 is fitted with equation (8), the 
resulting parameters values are obtained as: Ea0 = 1.48 
mmHg/ml, τC = 0.1555 s, ZC = 1.631, d = 0.28 s, τR = 0.07935 
s, ZR = 2.267 s, Ea,17 = 1.1 mmHg/ml, RMS = 0.026 mmHg/ml.
E E e ea a
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equation (13) becomes
where i is a time-instant during diastolic filling, Vi and
PLV,i are the monitored LV volume and pressure at this
time, and M = ρh / 4πR2. For the patient data (shown in
Figure 2), we can get the mean value for M during diastolic
filling, M = 8.03 × 10-6 mmHg/(ml/s2). Therefore, from
equation (15), we can calculate the values of Ep at various
instants during filling phase. We then plot Ep vs V, in Fig-
ure 6. By fitting equation (7) to these calculated values of
Ep, we obtain the values of the parameters Ep0 and zp, as:
zp = 0.0395 ml-1, Ep0 = 4.375 × 10-3 mmHg / ml  (16)
and the Ep function (corresponding to its expression given
by equation 7) as follows:
Ep = 4.375 × 10-3 e0.0395V  (17)
We now propose to adopt Ep as a measure of LV resistance-
to-filling.
Hence during ejection, both Ea and Ep are varying. During
ejection and filling phases, Ep can be calculated at any
time using equation (17). Likewise, Ea can be calculated
during ejection and filling phases using equation (8),
once its parameters have been determined by employing
equation (12-b & 12-b) during isovolumic contraction
and relaxation phases. Their values during the cardiac
cycle are listed in Table 1.
Clinical application results
The analyses, presented herewith, are now applied to clin-
ically obtained data consisting of the subject's left ven-
tricular (instant-to-instant) dimensions (obtained by
cineangiocardiograph) and chamber pressure (obtained
by cardiac catheterization). For each subject, passive and
active elastances are determined from the left ventricular
data. Table 2 provides the measured data and the model-
derived parameters for three subjects (subject HEL, DDM,
and ML). Subject HEL serves as a sample patient with
myocardial infarct, subject DDM with double vessel dis-
ease (DVD) and hypertension, treated with PTCA; subject
ML with idiopathic myocardial hypertrophy (IMH).
The variations of model-derived nonlinear passive and
active elastances for the subject HEL are shown in Figure
7. For this particular subject (HEL), the maximum active
elastance is 1.37 mmHg/ml. In Figure 8, we have plotted
Ea vs incremental pressure (P-Ped) for this patient HEL.
Note that the elastance is much higher at late-ejection
than early ejection. This is because of a continuing
sarcomere stress development and shortening. The active
elastance reaches its maximum value at late-ejection
(point 15), and thereafter decreases. However as shown in
Figure 7, even after the end of relaxation phase (point 21)
the active elastance continue to decrease into the filling
phase. This decrease can explain the suction effect during
the rapid filling sub-phase, even after LV filling has
commenced.
Figures 9 and 10 provide representations of the nonlinear
passive and active elastance for subject HEL (with hyper-
tension), DDM (myocardial infarct), and ML (idiopathic
myocardial hypertrophy). The Ep vs LV volume plots, in
Figure 9, clearly reveal that Ep increases exponentially with
increase LV volume; the parameters (EP0 and zp) character-
ize this relationship. The passive elastance curve is steeper
for a stiffer myocardium, with a corresponding bigger
value of the exponential coefficient Zp (subject ML). The
Ea vs incremental pressure (P-Ped) plots, in Figure 10,
reveal the development and decrease of Ea during systole,
which in turn governs the generation of LV pressure.
Passive elastance Ep vs LV volume for the data of figure 2Figur  6
Passive elastance Ep vs LV volume for the data of fig-
ure 2. Passive elastance Ep vs LV volume V, for the sample 
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Ea as a contractility index
Yet another way to study Ea variation is by means of the Ea
vs normalized time (t/ts) plot, shown in Figure 11. These
two figures 10 and 11 make us realize that Ea,max could be
regarded as an index of LV contractility. Hence, we
decided to plot Ea,max vs the traditional contractility indi-
ces of EF and (dP/dt)max. These plots are displayed in Fig-
ures 12 and 13. It is noted that Ea,max has a high degree of
correlation with both EF and (dP/dt)max. It is interesting to
compare our correlation-coefficient value (0.8972) with
the value of 0.89 obtained by Mehmel et al [12], although
this paper computes elastance as an extrinsic property =
[P/(V-Vd)]es.
Demonstrating LV suction phenomenon
The active elastance curve can explain some critical LV
physiological phenomena, namely LV pressure generation
during isovolumic contraction and LV suction during
early filling. The rapid decrease in elastance during isovo-
lumic relaxation extends into the filling phase, and can
explain the decrease in LV pressure (in Figure 7) even after
LV filling has commenced. Let us show how this happens,
by rewriting equation (15) as follows:
Pi - Pi-1 = (Ep,i + Ea,i)(Vi - Vi-1) + Vi (Ea,i - Ea,i-1)  (18)
by neglecting the  term, based on the calculation
of its value being of the order of 10-2 compared to (i) (Ep,i
+ Ea,i)(Vi - Vi-1), which is of the order of 100 and (ii) Vi(Ea,i
- Ea,i-1) which is the order of 101.
In equation (18), it is seen that Pi can be less than Pi-1 (or
that Pi - Pi-1 < 0) only if (Ea,i - Ea,i-1) is negative, i.e., active
elastance is decreasing. Now for subject H.E.L (Figure 1),
the computed values of Ea and Ep at these 2 instants (based
on equations 8 & 17) are:
Ep,22 = 0.2768 mmHg/ml, Ea,22 = 0.0393 mmHg/ml, Ea,21 =
0.1140 mmHg/ml, V22 = 105 ml, V21 = 90.6 ml  (19)
Substituting these values into equation (18) gives (P22 -
P21) = -3.22 mmHg, confirming decrease of pressure dur-
ing early filling.
Hence, our novel concept of "decreasing Ea during the
early phase of filling" enables us to explain the phenome-
non of decreasing LV pressure during the early stage of fill-
ing. In other words, it is suggested that the sarcomere
actin-myosin activity continues into the filling phase. The
decreasing Ea during the filling phase seems to reflect
decreasing sarcomeric activity during filling. Likewise, the
increase in Ea during isovolumic contraction is responsi-
ble for increase in LV pressure at constant volume, as dem-
onstrated by means of equation (11).
Demonstrating variation of LV pressure during ejection in 
terms of Ea and Ep
Similarly, both the active and passive elastances can
explain LV pressure variation during ejection, using equa-
tion (18). Let us show how this happens by just taking
two instants (t10 & t9), as follows:
P10 - P9 = (Ep,10 + Ea,10)(V10 - V9) + V10(Ea,10 - Ea,9)  (20)
Table 2: Clinical history, measured hemodynamic data and calculated passive and active elastance parameters (Ep and Ea) for subjects 
(HEL, DDM and ML). Where LVP: left ventricle chamber pressure, AOP: aortic pressure, EDV: end-diastolic volume, ESV: end-systolic 
volume, EF: ejection fraction, MI: myocardial infarct, DVD: double vessel disease, HTN: hypertension, IMH: idiopathic myocardial 
hypertrophy, Ea,max : maximum active elastance
Subject H.E.L D.D.M M.L
Disease MI, DVD DVD, HTN IMH
LVP (mmHg) 122/18 170/24 109/12
AOP (mmHg) 125/75 169/99 115/70
EDV/ESV (ml) 132.5/84.3 121.7/41.3 368/284
EF 0.36 0.66 0.23
Ep0 (mmHg/ml) 4.375 × 10-3 6.74 × 10-5 1.442 × 10-8
zp (ml-1) 0.0395 0.07499 0.05024
Ea0 (mmHg/ml) 1.48 4.4 0.595τC (s) 0.1555 0.207 0.1082
ZC 1.631 1.536 1.977
d (s) 0.28 0.26 0.18
τR (s) 0.07935 0.1536 0.1377
ZR 2.267 2.943 1.873
Ea,max (mmHg/ml) 1.37 3.58 0.57
dP / dtmax (mmHg/s) 1200 1475 1125
M dVi( )Page 8 of 13
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BioMedical Engineering OnLine 2005, 4:10 http://www.biomedical-engineering-online.com/content/4/1/10Substituting these computed values (listed in Table 1)
into equation (20) gives P10 - P9 = 1.92 mmHg, which is
approximately equal to the actual value of 2 mmHg.
Concluding comments
Previous works have described elastance as a derived
parameter from LV pressure-volume data, based on the
definition of P / (V - Vd) [9,10,12-14]. Also, Emax (given by
ESPVR) as illustrated on Figure 1 varies with different arte-
rial loading states and is therefore load dependent [21],
Pressure, active elastance Ea, and passive elastance Ep and total E = Ea + Ep for he data of figure 2Figure 7
Pressure, active elastance Ea, and passive elastance 
Ep and total E = Ea + Ep for the data of figure 2. Pres-
sure, active elastance Ea, passive elastance Ep, and total E = 
(Ea + Ep) for the sample subject shown in Figure 2. In this fig-
ure, 1–5 represents the isovolumic contraction phase, 5–17 
represents the ejection phase, and 17–21 represents the iso-
volumic relaxation phase, 21–37 represents the diastolic fill-
ing phase.
Active elastance vs. incremental pressureFigure 8
Active elastance vs. incremental pressure. Active 
elastance vs. incremental pressure (P-Ped) for the same sub-
ject as shown in Figure 2. The arrow direction indicates pro-
gression of time; 1–5: isovolumic contraction phase; 5–17: 
ejection phase. Note the rapid decrease in Ea during the iso-
volumic relaxation that also extends into the filling phase, and 
causes suction of blood into the LV even before initiation of 
left-atrial contraction.
LV volume and corresponding volume-dependent passive elastanceFigure 9
LV volume and corresponding volume-dependent 
passive elastance. Volume-dependent passive elastance 
(Ep) for subjects HEL, DDM, and ML.Page 9 of 13
(page number not for citation purposes)
BioMedical Engineering OnLine 2005, 4:10 http://www.biomedical-engineering-online.com/content/4/1/10and not an intrinsic index independent of LV loading
states.
Our definitions of Ep and Ea enable us to explain the phe-
nomena of (i) LV suction during early filing, (ii) LV
pressure rise during isovolumic contraction (iii) LV
pressure variation during the ejection phase, and (iv) LV
pressure drop during the relaxation phase. Both the con-
cepts of Ea and Ep are made possible by our redefining
elastance and compliance as
Active elastance vs. incremental pressureFigure 10
Active elastance vs. incremental pressure. Active 
elastance vs. incremental pressure for subjects HEL, DDM, 
and ML.
Active elastance vs. normalized timeFigure 11
Active elastance vs. normalized time. Active elastance 
vs normalized time (t/ts) for subjects HEL, DDM, and ML. 
Herein, ts is the duration from start-of-isovolumic contrac-
tion phase to end-of-isovolumic relaxation.
Ea,max vs EFFigure 12
Ea,max vs EF. Relating our contractility index Ea,max to EF fac-
tor, with r being the correlation coefficient.
Ea,max vs dP/dtmaxFigure 13
Ea,max vs dP/dtmax .Relating our contractility index Ea,max to 
the traditional contractility index dP/dtmax, with r being the 
correlation coefficient.Page 10 of 13
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BioMedical Engineering OnLine 2005, 4:10 http://www.biomedical-engineering-online.com/content/4/1/10dP = d(EV) = d(V/C) = VdE + EdV  (21)
Our concept of Ea enables us to explain (i) the generation
of pressure during isovolumic contraction and decrease of
pressure during isovolumic relaxation, when the volume
is constant, and (ii) the decrease of pressure during the
rapid filling phase.
Our concept of decreasing Ea along with increasing Ep dur-
ing filling, which enables us to explain the LV suction
effect during early filling, is indirectly supported by the
work of Shoucri [22]. He has indicated that the LV wall
stress during the filling phase is made up of two
components: (i) a passive increasing component due to
LV pressure and (ii) an active decreasing component due
to decreasing active fiber stress.
However, the determination of this active fiber stress in
his paper is empirical and not based on a well-defined
concept and expression for Ea, as provided by us.
Finally, both Ea and Ep are invoked to explain the varia-
tions of pressure during the ejection and filling phases.
From the viewpoint of intrinsic indices of LV assessment,
Ep can represent LV myocardial stiffness property and
resistance to LV filling. On the other hand, Ea has been
shown to correspond to LV contractility, by means of
Figures 12 & 13. Therein, we have shown a high degree of
correlation between Ea,max and (dP/dt)max as well as EF.
In future, we can also couple our LV model (of Ep and Ea)
with an arterial lumped-parameter model (consisting of
total peripheral resistance R, total arterial compliance C,
aortic characteristic impedance Z0 and inertial L) in order
to simulate and explain the mechanisms of chronic
hypertensive states [23], in terms of alteration in Ea itself
as a measure of LV adaptation to chronic hypertension
induced in the circulation system.
Appendix: Derivation of Equation (5)
Dynamic equilibrium of the LV myocardial element gives
(based on figure 14):
where the myocardial element mass, me = ms Ae, ms (the
myocardial surface-density or mass per unit surface area)
= ρh, ρ is the myocardial density, and u is the radial
displacement, dPel and dPLV are the incremental elastic-
recoil and left ventricular pressures (as depicted in Figure
A-1).
Dynamic equilibrium of a myocardial elementFigure 14
Dynamic equilibrium of a myocardial element. Dynamic equilibrium of a myocardial element. Element mass me = ρ(2r1dθ1)(2r2dθ2)h = (ρh)(4r1r2dθ1θ2) = ρhAe = msAe; dσi = (dPel)(ri) / (2h), (i = 1, 2); dPel is the incremental elastic-recoil pressure. 
For dynamic equilibrium of the myocardial element, me  + 2(dσ1)(2r2dθ2h) + 2(dσ2)(2r1dθ1h) - AedPLV = 0, or me  + AedPel - 
AedPLV = 0. For our LV spherical geometry model, r1 = r2 and dσ1 = dσ2.
du du
m du dP A dP A
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BioMedical Engineering OnLine 2005, 4:10 http://www.biomedical-engineering-online.com/content/4/1/10Now since,
By assuming r1 = r2 = R
we can write:
where ρs is the surface density, M = ρsh, and V is the LV vol-
ume. Now, referring to Figure A-1,
and
where Re is the resistance to LV filling (through the open
mitral-valve), ρf is the blood density and v is the blood
velocity at site 2.
Let us now define incremental elastic recoil pressure (in
response to incremental LV pressure dPLV) as:
Hence, from equations (A-1, A-4, A-7 & A-8), we have
Introducing the term elastance (= 1/C), we can put down
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